(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(2.16%) $83.11
(1.98%) $1.752
(1.90%) $2 254.80
(1.41%) $25.10
(1.45%) $922.85
(0.37%) $0.927
(0.73%) $10.85
(0.13%) $0.792
(0.15%) $92.58
Live Chart Being Loaded With Signals
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye...
Stats | |
---|---|
Today's Volume | 1.00 |
Average Volume | 56.00 |
Market Cap | 66.11M |
EPS | $-0.420 ( 2021-11-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -20.22 |
ATR14 | $0.156 (0.44%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-11-02 | From Stephen | Sell | 250 | Common Stock |
2021-11-02 | Mann Brenda | Sell | 62 | Common Stock |
2021-10-04 | Mann Brenda | Sell | 62 | Common Stock |
2021-10-04 | From Stephen | Sell | 249 | Common Stock |
2021-09-02 | From Stephen | Sell | 253 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 98 transactions |
Buy: 1 959 813 | Sell: 207 057 |
Volume Correlation
EyeGate Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
BMTC | 0.948 |
XPDI | 0.926 |
FATE | 0.912 |
TCDA | 0.908 |
GRAY | 0.905 |
ENPH | 0.896 |
BCAB | 0.895 |
ODT | 0.887 |
HECCU | 0.884 |
LHDX | 0.879 |
10 Most Negative Correlations | |
---|---|
TIG | -0.936 |
CCRC | -0.928 |
FRGI | -0.917 |
ARNA | -0.903 |
DSPG | -0.899 |
ACIW | -0.899 |
NTES | -0.896 |
EXAS | -0.896 |
APEN | -0.896 |
GGAL | -0.895 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
EyeGate Pharmaceuticals Correlation - Currency/Commodity
EyeGate Pharmaceuticals Financials
Annual | 2020 |
Revenue: | $12 059.00 |
Gross Profit: | $12.06 (0.10 %) |
EPS: | $-2.54 |
Q3 | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.420 |
Q2 | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.350 |
Q1 | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.370 |
Financial Reports:
No articles found.
EyeGate Pharmaceuticals
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. The company is headquartered in Waltham, Massachusetts and currently employs 11 full-time employees. The firm is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The firm's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues through its drug delivery system, the EyeGate II Delivery System. The firm is developing EGP-437 for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and/or ciliary body, and macular edema, an abnormal thickening of the macula associated with the accumulation of excess fluids in the extracellular space of the neurosensory retina. The EyeGate II Delivery System is designed to deliver optimal quantities of drugs to the anterior or posterior segments of the eye.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators